Oxymap

Reykjavik, Iceland Founded: 2002 • Age: 24 yrs
Retinal Imaging technology to assess retinal oxygen saturation and vessel width
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Oxymap

Oxymap is a company based in Reykjavik (Iceland) founded in 2002. Oxymap offers products and services including Oxymap T1. Oxymap operates in a competitive market with competitors including Sensimed, i-Optics, Implandata, Inoveon and Azul Optics, among others.

  • Headquarter Reykjavik, Iceland
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $55.01 K (USD), Grant

    Oct 31, 2015

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Oxymap

Oxymap offers a comprehensive portfolio of products and services, including Oxymap T1.

Product name locked
Category locked
Primary

Measures oxygen saturation in retinal blood vessels for disease diagnosis and monitoring.

Funding Insights of Oxymap

Investors in Oxymap

Oxymap has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Oxymap

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Oxymap

Investments
Premium access

Investment portfolio details for Oxymap

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Oxymap

Premium access

Detailed financials for Oxymap

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Oxymap Comparisons

Oxymap Primary company
Description
Retinal Imaging technology to assess retinal oxygen saturat...
Location
Reykjavik, Iceland
Founded Year
2002
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Oxymap

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Oxymap

Oxymap operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sensimed, i-Optics, Implandata, Inoveon and Azul Optics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
A contact lens-based platform for glaucoma monitoring is offered.
Locked Locked Locked
i-Optics specializes in providing advanced retina and cornea imaging systems for medical professionals.
Locked Locked Locked
Intraocular pressure is monitored continuously via an implantable microsensor.
Locked Locked Locked
Eye disease detection services including diabetic retinopathy are provided.
Locked Locked Locked
Device for assessing the eye health against damaging light
Locked Locked Locked
Non-invasive visual electrophysiology devices are supplied for ophthalmological diagnosis.
Premium access

Detailed competitors of Oxymap

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Oxymap

Premium access

Complete news archive for Oxymap

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oxymap

Oxymap was founded in 2002 and raised its 1st funding round 13 years after it was founded.

Oxymap is headquartered in Reykjavik, Iceland.

A non-invasive imaging solution for retinal oxygen saturation and vessel width assessment was developed by Oxymap, founded in 2002 in Reykjavik, Iceland. The technology serves as an add-on to fundus cameras, enabling metabolic and structural retinal analysis for conditions like diabetic retinopathy and glaucoma. Spectral images are processed automatically by software to detect vessels and measure optical density, with the device holding CE marking in the medical imaging sector.

Oxymap's top competitors include 2EyesVision, Sensimed and Diopsys.

Oxymap offers Oxymap T1.

Oxymap has 2 investors. Key investors include European Union, and EIC Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available